rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
2007-4-30
|
pubmed:abstractText |
A novel class of selective Tie-2 inhibitors was derived from a multi-kinase inhibitor 1. By reversing the amide connectivity and incorporating aminotriazine or aminopyridine hinge-binding moieties, excellent Tie-2 potency and KDR selectivity could be achieved with 3-substituted terminal aryl rings. X-ray co-crystal structure analysis aided inhibitor design. This series was evaluated on the basis of potency, selectivity, and rat pharmacokinetic parameters.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0960-894X
|
pubmed:author |
pubmed-author:AlbrechtBrian KBK,
pubmed-author:BellonSteveS,
pubmed-author:CaenepeelSeanS,
pubmed-author:CeeVictor JVJ,
pubmed-author:ChaffeeStuart CSC,
pubmed-author:EmeryMauriceM,
pubmed-author:FretlandJenneJ,
pubmed-author:GallantPaulP,
pubmed-author:Geuns-MeyerStephanie DSD,
pubmed-author:GuYanY,
pubmed-author:HodousBrian LBL,
pubmed-author:HughesPaul EPE,
pubmed-author:JohnsonRebecca ERE,
pubmed-author:KimJoseph LJL,
pubmed-author:LongAlexander MAM,
pubmed-author:MorrisonMichaelM,
pubmed-author:OlivieriPhilip RPR,
pubmed-author:PatelVinod FVF,
pubmed-author:PolverinoAnthonyA,
pubmed-author:RosePaulP,
pubmed-author:WangLingL,
pubmed-author:ZhaoHuilinH
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2886-9
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:17350837-Animals,
pubmed-meshheading:17350837-Crystallography, X-Ray,
pubmed-meshheading:17350837-Drug Design,
pubmed-meshheading:17350837-Male,
pubmed-meshheading:17350837-Models, Molecular,
pubmed-meshheading:17350837-Molecular Structure,
pubmed-meshheading:17350837-Rats,
pubmed-meshheading:17350837-Rats, Sprague-Dawley,
pubmed-meshheading:17350837-Receptor, TIE-2,
pubmed-meshheading:17350837-Structure-Activity Relationship,
pubmed-meshheading:17350837-Triazines
|
pubmed:year |
2007
|
pubmed:articleTitle |
Synthesis, structural analysis, and SAR studies of triazine derivatives as potent, selective Tie-2 inhibitors.
|
pubmed:affiliation |
Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, MA 02139, USA. bhodous@amgen.com
|
pubmed:publicationType |
Journal Article
|